Ireland
--:--IST
Recruiting Observational

Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis

NCT05356806 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2022-01-10
Last updated
2024-12-12

Condition(s) studied

Peri-implant Mucositis

Investigational drug(s) / intervention(s)

Supportive periodontal and periimplant care

Supportive periodontal and periimplant care: Periodontal and peri-implant maintenance therapy will be carried out at baseline, 3 and 6-month visit. This session will include the removal of biofilm and calculus on teeth and implants (except those that have just been restored) with an ultrasonic device using a plastic tip ( for implants. and a conventional metal tip ( for teeth. At the end, polishing will be done with a rubber cup Subsequently, patients will be explained that they must continue with their usual oral hygiene technique on their teeth, using the same type of brush (which can be electric or manual), interproximal devices, toothpaste or mouthwash used to date. Finally, they will receive specific instructions for the supragingival biofilm control in the area of the new restoration and will be given interdental brushes that suit to the space

Study summary

the objective of this study is to determine the incidence of peri-implant mucositis in patients with treated periodontitis and enrolled in periodontal maintenance and to evaluate the associated risk indicators. An analytical prospective observational study will be carried out, with an initial follow-up of 12 months.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Over 18 years of age, able to comply with the protocol and comply with the established visits. * Patients with treated periodontitis and enrolled in periodontal maintenance (last maintenance therapy received between 4 and 6 months maximum before inclusion in the study) (Chapple et al., 2018, Sanz et al., 2020). * Patients with osseointegrated dental implants waiting for their prosthodontic rehabilitation (fixed prosthesis \[individual, partial or complete\], hybrid or overdenture). * Physical or mental conditions that make it possible to perform appropiate oral hygiene Exclusion Criteria: * Patients with untreated periodontitis. * Totally edentulous patients. * Patients with peri-implant diseases. * Pregnant or in lactating-period patients. * Patients undergoing treatment with medication that affects the periodontal/peri-implant status or the immune system (phenytoin, calcium antagonists, corticosteroids or anti-inflammatories). * Patients who have taken antibiotics in the last month.

Primary outcome measure(s)

  • Incidence of peri-implant mucositis — 12 months
    The risk of developing PM (patient with at least one implant who has bleeding on probing, with or without suppuration and without progressive radiographic bone loss) during a follow-up period of 12 months.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry, University Complutense of Madrid (UCM) Madrid Spain Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05356806 on ClinicalTrials.gov ↗ ← All trials in Spain